RP-15081

N/A

Report date: 2025/01/26 17:56:59
NME

Base Information

Drug NameRP-15081
Drug Alias NameDNA-directed polymerase theta inhibitor program (Rhizen Pharmaceuticals)Pol theta inhibitor (Rhizen Pharmaceuticals)RP-15081
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA polymerase theta inhibitors
TargetsDNA polymerase theta
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRhizen Pharmaceuticals Sa
China Registration ClassN/A

Develop Information

Active CompaniesRhizen Pharmaceuticals Sa
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A